Filter posts

Couldn’t Make it to San Francisco This Week?

Me neither, so here is what I am reading for updates about the 32nd Annual JPMorgan Healthcare …

BIO White Paper Highlights Key Industry Legislation and its Impact on the Industry

Innovative biotech companies at all stages of the development process are working toward next generation …

What’s Behind the Biotech IPO Boom?

Everyone knows that it’s been a knock-out year for the biotech sector in the public …

The Value of Partnering Continues to be a Draw for BIO Events

Last month’s BIO Convention in China saw 700 partnering meetings between executives from biotechnology, pharmaceutical companies and investment …

Biotech Stocks Hit Record Highs...Again

Biotech stocks hit an all-time high this week, driven by strong performance among large cap …

Show Me the Money: Reimbursement in an ACA World

A panel at the BIO CEO & Investor Conference focused on reimbursement discussed value from a …

Orphan Drugs: Making Rare Diseases Rarer

A panel at the BIO CEO & Investor Conference provided an analysis of the thriving …

Putting a Ring on It: Advice on Successful Drug Development Collaborations

Drug development partnerships can look lucrative to small biotechs eager to monetize their discoveries, but, …

Small Biotech Companies and China: 5 Keys to Success

Big pharmaceutical countries aren’t the only ones investing in China. Emerging and mid-sized biotech companies are also …

Despite Low Funding, Biotech Productivity Remains High In 2013

At the 2013 BIO CEO & Investor Conference, John Milligan, President and COO of Gilead …